Shree Ganesh Biotech (India) Ltd - 539470 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
PFA08-01-2024
Shree Ganesh Biotech (India) Ltd - 539470 - Clarification Letter To BSE Ltd In Reference To Advisory Letter Received From BSE Ltd Dated 28.12.2023
Clarification Letter to BSE Ltd in reference to advisory letter received from BSE Ltd dated 28.12.202301-01-2024
Shree Ganesh Biotech (India) Ltd - 539470 - Advisory Letter Received From BSE Limited Dated 28.12.2023
Advisory Letter received from BSE Limited dated 28.12.2023.28-12-2023
Shree Ganesh Biotech (India) Ltd - 539470 - Board Meeting Outcome for Un-Audited Financial Result Quarter And Half Year Ended On 30Th September 2023 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015.
Requirements) Regulations, 2015 In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith Un-audited financial result for quarter and half year ended on 30th September, 2023 and The meeting commenced at 03.30 P.M. and concluded at 04.00 P.M. Kindly take the same on your record and oblige. Thanking You.08-11-2023
Shree Ganesh Biotech (India) Ltd - 539470 - Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.
Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 ,inter alia, to consider and approve Notice pursuant to regulation 29 of SEBI (LODR), Regulation, 2015, be and is hereby given that the meeting of the Board of Directors of the Company will be held on Wednesday, November 8, 2023 inter alia, to consider the Un-Audited financial results of the company for quarter and half year ended on September 30, 2023 and also transact other business activities. Please take the above intimation in your records. Thanking you.26-10-2023
Shree Ganesh Biotech (India) Ltd - 539470 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shiv Corporation20-10-2023